David A. Ralph
14Patents
3h-index
7Co-inventors
53Inventor score
Filing activity: Jul 31, 1996 → May 15, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5882864A | Biomarkers and targets for diagnosis, prognosis and management of prostate disease | Chemistry; Metallurgy | 135 | Expired |
| US6218529A | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer | Chemistry; Metallurgy | 70 | Expired |
| US6190857A | Diagnosis of disease state using MRNA profiles in peripheral leukocytes | Physics | 39 | Expired |
| US11007272B1 | Compounds and methods for diagnosis and treatment of viral infections | Emerging Cross-Sectional Technologies | 3 | Active |
| US11833170B2 | Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking | Human Necessities | 1 | Active |
| US7332270B1 | Diagnosis of disease state using mRNA profiles in peripheral leukocytes | Physics | 1 | Expired |
| US12404349B2 | Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymers | Chemistry; Metallurgy | 0 | Active |
| US11859023B2 | Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof | Human Necessities | 0 | Active |
| US12297222B2 | CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker | Chemistry; Metallurgy | 0 | Active |
| US10408836B2 | Methods of detecting influenza virus | Physics | 0 | Active |
| US12006339B2 | CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker | Chemistry; Metallurgy | 0 | Active |
| US12178829B2 | Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking | Human Necessities | 0 | Active |
| US11590236B2 | Compositions and methods for altering macrophage phenotype | Human Necessities | 0 | Active |
| US12005122B2 | Compounds and methods for diagnosis and treatment of viral infections | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.